08Jun
08Jun
Smart glasses give legally blind man second chance to see his wife at their wedding
A pair of eSight 3 smart glasses have given Airey something close to 20/20 vision. Recently Airey and his family were able to recreate their wedding while he wore the device. The wedding was at the same church from 15 years ago and the ceremony included the same cake and many of the same guests. Read more >>
07Jun
“What Grinds My Gears” Investor Edition
There are many great resources about what you should do as a presenter pitching your startup to a group of investors. I decided to take the opposite approach, offering advice on what not to do as a presenter. We polled several prominent investors across the Boston area about "What Grinds Their Gears" as an investor hearing startup presentations. As a startup founder, please keep these tips in mind when presenting to investors and use their guidance to help perfect your...
07Jun
Chronix presents head/neck cancer data at ASCO
Chronix Biomedical presents positive data on prognostic test in head/neck cancer study at ASCO. Read more >>
04Jun
Finish Line: Will Myomo Raise Enough Under Reg A+ to List on NYSE MKT?
We last wrote about Myomo, a commercial stage medical robots company (kind of like the Bionic Man), in March. Myomo was in the process of using Reg A+ to raise growth capital. Read more >>
04Jun
Will Wasabi’s cheap, fast commodity storage disrupt Amazon S3?
After starting six companies with fellow tech veteran Jeff Flowers since 1980, Wasabi Technologies Inc. co-founder David Friend has clearly learned to name names when it comes to competition. Read more >>
03Jun
Meet Blurr — the Gen Z Answer to Instagram
The geo-fencing app closed an initial seed round of $200,000 from angel investors in 2016. Read more >>
02Jun
JDRF Invests in TetraGenetics’ Innovative Approach to Type 1 Diabetes Prevention
A unique scientific approach to preventing, treating and, perhaps one day, curing type 1 diabetes is being coupled with JDRF’s equally innovative approach to funding such studies in a new partnership that might move the promise of a preventive therapy and improved treatment for the condition closer to reality. “This is a very targeted therapeutic approach to addressing type 1 diabetes,” says Dr. Ted Clark, the Chief Scientific Officer for TetraGenetics, a company that has been working for the past several...
02Jun
A Conversation With Jonathan Naft, CPO
In this issue, O&P News poses five questions to Jonathan Naft, CPO. Naft is the president and founder of Geauga Rehabilitation Engineering Inc., and the vice president and general manager of Myomo Inc. He is an American Board for Certification in Orthotics, Prosthetics and Pedorthics (ABC)-certified orthotist and prosthetist. He is also an electrical engineer and biomedical engineer. Read more >>
01Jun